- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Estrogen receptor positive advanced metastatic breast cancer
Total 119417 results
-
Stemline Therapeutics, Inc.CompletedAdvanced ER+, HER2-Negative Breast CancerUnited States
-
Velindre NHS TrustAstraZeneca; Cardiff and Vale University Health Board; Covance; Cenduit LLCActive, not recruitingEstrogen Receptor Positive Breast CancerUnited Kingdom
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
PfizerCompletedBreast CancerAustralia, India
-
Celcuity, Inc.Completed
-
Hoffmann-La RocheTerminatedBreast CancerItaly, United States, Korea, Republic of, Canada, Czechia, Spain, Australia, Bulgaria, China, Finland, France, Greece, Poland, Portugal, Taiwan, Thailand, Turkey, Colombia, Bosnia and Herzegovina, Mexico, Peru, Romania, Russian Federation and more
-
Novartis PharmaceuticalsGlaxoSmithKlineCompletedNeoplasms, BreastBelgium, United Kingdom, Croatia, Hungary, Argentina, Australia, Germany, Israel, Japan, Poland, Russian Federation, Spain, France, Korea, Republic of, Hong Kong, United States, Brazil, Bulgaria, China, India, Ireland, Italy, Philip... and more
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditions
-
Northwestern UniversityNational Cancer Institute (NCI); MedImmune LLC; Avon Breast Cancer FoundationCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu NegativeUnited States
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
Fudan UniversityActive, not recruiting
-
NSABP Foundation IncNational Cancer Institute (NCI)Active, not recruitingBreast CancerUnited States, Puerto Rico
-
Eli Lilly and CompanyCompletedNon-Hodgkin's Lymphoma | Metastatic Cancer | Malignant Mesothelioma | Metastatic Breast Cancer | Non-small Cell Lung Cancer | Advanced CancerUnited States, Puerto Rico, Italy
-
Dana-Farber Cancer InstituteNovartisTerminatedMetastatic Hormone-Receptor-Positive (HR+) Breast Cancer | HER2-Negative Breast Cancer | Metastatic Epithelial Ovarian CancerUnited States
-
Novartis PharmaceuticalsCompletedColorectal Cancer, Triple Negative Breast Cancer, NSCLC - AdenocarcinomaUnited States, France, Taiwan, Canada, Italy, Singapore, Belgium, Spain, Israel
-
University of California, San FranciscoDana-Farber Cancer Institute; Translational Breast Cancer Research ConsortiumCompletedMetastatic Breast Cancer | Hormone Receptor PositiveUnited States
-
Institut Claudius RegaudTerminated
-
Boehringer IngelheimCompletedNeoplasmsSpain, Korea, Republic of, Belgium, Taiwan, United Kingdom, Austria, France, Netherlands, Ireland, Sweden
-
Syndax PharmaceuticalsCompletedBreast Cancer | Estrogen Receptor Positive Breast CancerUnited States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsBreast International Group; SOLTI Breast Cancer Research GroupCompletedNeoplasms, BreastFrance, Spain, United Kingdom, Belgium, Argentina, Czechia, Germany, Italy, Norway, Russian Federation, Sweden, Taiwan, Hong Kong, Brazil, Hungary, India, Korea, Republic of, Pakistan, Peru, Romania, South Africa, Ukraine, Canada, Lit...
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced orKorea, Republic of
-
Eli Lilly and CompanyTerminatedMetastatic Breast CancerUnited States, Puerto Rico
-
Odonate Therapeutics, Inc.TerminatedBreast CancerKorea, Republic of, United States, Spain, Canada, Singapore, Taiwan, Australia, Belgium, Thailand, Hungary, Germany, United Kingdom, France, Ukraine, Austria, Czechia, Italy, Poland, Russian Federation
-
Odonate Therapeutics, Inc.TerminatedBreast CancerUnited States, Spain, Korea, Republic of, Taiwan, Australia, Canada
-
University of WashingtonNational Cancer Institute (NCI)TerminatedRecurrent Breast Carcinoma | Estrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
Pantarhei Oncology B.V.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Loyola UniversityCompletedMetastatic Breast Cancer | Estrogen Receptor Positive | Adult WomenUnited States
-
Novartis PharmaceuticalsCompleted
-
Genentech, Inc.TerminatedBreast CancerUnited States, Spain, United Kingdom, Germany, Korea, Republic of, Australia
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Spain, Belgium, Hong Kong, France
-
Hoffmann-La RocheCompletedHER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast CancerIndia
-
University Health Network, TorontoCompletedMicrosatellite Stable Colorectal Carcinoma | Platinum Resistant Epithelial Ovarian Cancer Type II | Estrogen Receptor Positive and HER2 Negative Breast CancerCanada
-
University of ArkansasOSI PharmaceuticalsTerminated
-
Centre Hospitalier Universitaire de BesanconPierre Fabre MedicamentTerminated
-
Southwest Oncology GroupNovartis; AstraZenecaTerminatedBreast CancerUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Hoffmann-La RocheTerminatedBreast Cancer | Gastric CancerItaly, Argentina, Canada, France, Greece, Portugal, Slovakia, Brazil, Russian Federation, Spain, Germany, Serbia
-
Spanish Breast Cancer Research GroupPfizer; AstraZenecaCompletedMetastatic Breast CancerSpain, Israel, Hungary, Austria
-
Gilead SciencesCompletedSolid Tumors and LymphomasUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownMetastatic Breast CancerChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Recurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7 | Postmenopausal | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States
-
Novartis PharmaceuticalsCompletedBreast CancerFrance, Singapore, Italy, Korea, Republic of, Taiwan, United Kingdom, Spain, United States
-
Istituto Oncologico Veneto IRCCSUniversity of PadovaCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
AbbVieTerminatedCancer | Breast CancerUnited States, Germany, Japan, Puerto Rico
-
ArQule, Inc. (a wholly owned subsidiary of Merck...TerminatedOvarian Cancer | Endometrial Cancer | Solid TumorsUnited States
-
Novartis PharmaceuticalsCompletedEstrogen Receptor Positive Breast Cancer | Advanced Solid Tumors With an Alteration of the PIK3CA GeneUnited States, Netherlands, Spain, Germany, United Kingdom